Tim Kutzkey, Ph.D., is a Managing Partner of The Column Group. Since joining the firm in 2007 he has contributed to the conception, formation, and management of more than a dozen portfolio companies. He currently serves as the Chairman of the Board of Directors of Neurona Therapeutics, Surrozen, and Nura Bio, all companies for which …
Dr. Goeddel was the first scientist hired by Genentech and from 1978 to 1993 served in various positions, including Staff Scientist, Director of Molecular Biology and Genentech Fellow. His pioneering work in the fields of gene cloning and expression of human proteins was the basis for five marketed therapeutics developed by Genentech, including human insulin, …
Peter Svennilson founded The Column Group in 2007 and has worked in venture capital and finance for over 35 years. He was the Chairman of Aragon Pharmaceuticals from startup until it was sold to Johnson & Johnson in 2013 and was the Chairman of Seragon Pharmaceuticals until it was sold to Genentech/ Roche in 2014. …
